Last update: May 22, 2021
Minimal risk for breastfeeding and infant.
It is excreted in breast milk in insignificant amounts and no problems have been observed in the majority of infants of mothers who took it (Golstein, 2000, Kafetzis 1981, Ito 1993, Nau 1987) except for occasional episodes of mild diarrhea, rash or drowsiness that did not require medical attention (Goldstein 2009, Benyamini 2005, Ito 1993).
It is considered medication compatible with breastfeeding by relevant authors and scientific societies (Rowe 2013, Nahum 2006, Mahadevan 2006, Bar-Oz 2003, CDC 2001, Chin 2000, Fulton 1992).
It is a medication commonly used in Pediatrics and considered an essential medicine for pediatric use by WHO (WHO 2013).
The possibility of transient gastroenteritis due to alteration of the intestinal flora in infants whose mothers take antibiotics should be taken into account (Benyamini 2005, Ito 1993, Kafetzis 1981).
American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).
List of WHO essential medicines: compatible with breastfeeding (WHO / UNICEF 2002).
We do not have alternatives for (6R)-6-[α-d-(4-Hydroxyphenyl)glycylamino]penicillanic acid since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.